Avantor, Inc. (NYSE:AVTR) Receives $27.69 Consensus Target Price from Brokerages

Avantor, Inc. (NYSE:AVTRGet Free Report) has earned an average rating of “Moderate Buy” from the thirteen brokerages that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $27.69.

Several equities analysts recently weighed in on AVTR shares. Barclays reduced their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research report on Friday, October 25th. Robert W. Baird dropped their price objective on Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a research note on Monday, October 28th. UBS Group lowered their target price on Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a research note on Tuesday, October 8th. Wells Fargo & Company cut their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research note on Monday, October 28th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $34.00 target price on shares of Avantor in a research report on Thursday, September 26th.

Read Our Latest Research Report on Avantor

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. UMB Bank n.a. bought a new position in shares of Avantor in the third quarter worth approximately $49,000. Nisa Investment Advisors LLC increased its holdings in shares of Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after buying an additional 835 shares during the last quarter. GAMMA Investing LLC increased its holdings in shares of Avantor by 89.9% in the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after buying an additional 1,285 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its position in shares of Avantor by 278.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock valued at $130,000 after buying an additional 3,700 shares in the last quarter. Finally, Quarry LP lifted its holdings in shares of Avantor by 4,489.1% during the 2nd quarter. Quarry LP now owns 6,333 shares of the company’s stock worth $134,000 after acquiring an additional 6,195 shares during the last quarter. Institutional investors own 95.08% of the company’s stock.

Avantor Stock Performance

Shares of AVTR opened at $21.41 on Thursday. The stock has a 50 day moving average of $21.80 and a 200 day moving average of $23.36. The company has a market capitalization of $14.57 billion, a price-to-earnings ratio of 46.54, a PEG ratio of 2.75 and a beta of 1.29. Avantor has a 12 month low of $19.59 and a 12 month high of $28.00. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84.

About Avantor

(Get Free Report

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

See Also

Analyst Recommendations for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.